As of 2026-05-27, the EV/EBITDA ratio of Beijing Bohui Innovation Biotechnology Co Ltd (300318.SZ) is -40.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300318.SZ's latest enterprise value is 5,778.56 mil CNY. 300318.SZ's TTM EBITDA according to its financial statements is -141.28 mil CNY. Dividing these 2 quantities gives us the above 300318.SZ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 35.2x | 28.6x |
| Forward P/E multiples | 14.5x - 17.7x | 16.4x |
| Fair Price | (5.60) - (0.15) | (3.56) |
| Upside | -207.9% - -102.8% | -168.5% |
| Date | EV/EBITDA |
| 2026-05-22 | -40.61 |
| 2026-05-21 | -40.21 |
| 2026-05-20 | -41.36 |
| 2026-05-19 | -42.17 |
| 2026-05-18 | -42.00 |
| 2026-05-15 | -41.71 |
| 2026-05-14 | -41.94 |
| 2026-05-13 | -43.16 |
| 2026-05-12 | -43.68 |
| 2026-05-11 | -45.06 |
| 2026-05-08 | -43.97 |
| 2026-05-07 | -42.81 |
| 2026-05-06 | -43.33 |
| 2026-04-30 | -43.27 |
| 2026-04-29 | -43.45 |
| 2026-04-28 | -43.04 |
| 2026-04-27 | -43.04 |
| 2026-04-24 | -42.98 |
| 2026-04-23 | -42.75 |
| 2026-04-22 | -43.39 |
| 2026-04-21 | -43.16 |
| 2026-04-20 | -43.45 |
| 2026-04-17 | -43.85 |
| 2026-04-16 | -44.72 |
| 2026-04-15 | -45.35 |
| 2026-04-14 | -44.72 |
| 2026-04-13 | -44.66 |
| 2026-04-10 | -45.12 |
| 2026-04-09 | -45.12 |
| 2026-04-08 | -46.11 |
| 2026-04-07 | -45.30 |
| 2026-04-03 | -44.43 |
| 2026-04-02 | -45.82 |
| 2026-04-01 | -45.76 |
| 2026-03-31 | -44.72 |
| 2026-03-30 | -45.35 |
| 2026-03-27 | -45.18 |
| 2026-03-26 | -44.14 |
| 2026-03-25 | -44.66 |
| 2026-03-24 | -44.60 |
| 2026-03-23 | -43.21 |
| 2026-03-20 | -45.12 |
| 2026-03-19 | -46.28 |
| 2026-03-18 | -47.26 |
| 2026-03-17 | -46.80 |
| 2026-03-16 | -47.20 |
| 2026-03-13 | -46.92 |
| 2026-03-12 | -46.92 |
| 2026-03-11 | -47.03 |
| 2026-03-10 | -47.38 |